0001140361-14-030442.txt : 20140801
0001140361-14-030442.hdr.sgml : 20140801
20140801180655
ACCESSION NUMBER: 0001140361-14-030442
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140730
FILED AS OF DATE: 20140801
DATE AS OF CHANGE: 20140801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalanche Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1035 O?BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-272-6269
MAIL ADDRESS:
STREET 1: 1035 O?BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCLAUGHLIN JOHN PETER
CENTRAL INDEX KEY: 0001277967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 141011098
MAIL ADDRESS:
STREET 1: C/O PDL BIOPHARMA, INC.
STREET 2: 932 SOUTHWOOD BOULEVARD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
4
1
doc1.xml
FORM 4
X0306
4
2014-07-30
0
0001501756
Avalanche Biotechnologies, Inc.
AAVL
0001277967
MCLAUGHLIN JOHN PETER
C/O AVALANCHE BIOTECHNOLOGIES, INC.
1035 O'BRIEN DRIVE, SUITE A
MENLO PARK
CA
94025
1
0
0
0
Stock Option (Right to Buy)
17.00
2014-07-30
4
A
0
75000
0.00
A
2024-07-29
Common Stock
75000
75000
D
One-third (1/3) of the total number of shares subject to the stock option shall vest and become exercisable annually, so that all of the shares subject to the stock option shall be vested and exercisable on the third anniversary of July 30, 2014, subject to the Reporting Person's continuous service to the Issuer.
/s/ Michael Swartzburg, Attorney-in-Fact for John McLaughlin
2014-08-01